Moreover, we found that the system Xc(−) inhibitor SAS upregulates TFRC expression, and TFRC-depleted, MYCN-overexpressed NB cells exhibit high resistance to SAS (Fig. S1E–G). Here, MYCN is linked to neuroblastoma.